Havrix (Hepatitis A-Impfstoff) 1440 El.U/ml - Injektionssuspension in einer Fertigspritze New
Recall
|
Medicines
|
20/02/2026
The marketing authorisation holder informed its customers on February 20, 2026 that the prefilled syringe of the vaccine for adults was mistakenly labeled as a “Junior” vaccine. For this reason, the affected batch is being recalled.
| Name of the medicinal product | Havrix (Hepatitis A-Impfstoff) 1440 El.U/ml - Injektionssuspension in einer Fertigspritze |
|---|---|
| Marketing authorisation number(s) | 2-00173 |
| CIP code | 1301057 |
| Marketing authorisation holder | Glaxosmithkline Pharma GmbH |
| Batch number(s) | AHAVC221AC |
| Expiry date | 06/30/2028 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-5557 |
Further inquiry note
Page last modified:
20/02/2026